250 related articles for article (PubMed ID: 7692000)
1. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis.
Chamberlain MC; Dirr L
J Clin Oncol; 1993 Oct; 11(10):1978-84. PubMed ID: 7692000
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related central nervous system lymphomas.
Chamberlain MC; Kormanik PA
J Neurooncol; 1999 Jul; 43(3):269-76. PubMed ID: 10563433
[TBL] [Abstract][Full Text] [Related]
3. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
5. Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.
Chamberlain MC; Johnston SK; Van Horn A; Glantz MJ
J Neurooncol; 2009 Feb; 91(3):271-7. PubMed ID: 18820836
[TBL] [Abstract][Full Text] [Related]
6. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Chamberlain MC; Kormanik P; Glantz M
Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Pels H; Schmidt-Wolf IG; Glasmacher A; Schulz H; Engert A; Diehl V; Zellner A; Schackert G; Reichmann H; Kroschinsky F; Vogt-Schaden M; Egerer G; Bode U; Schaller C; Deckert M; Fimmers R; Helmstaedter C; Atasoy A; Klockgether T; Schlegel U
J Clin Oncol; 2003 Dec; 21(24):4489-95. PubMed ID: 14597744
[TBL] [Abstract][Full Text] [Related]
8. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
[TBL] [Abstract][Full Text] [Related]
9. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
Schlegel U; Pels H; Glasmacher A; Kleinschmidt R; Schmidt-Wolf I; Helmstaedter C; Fliessbach K; Deckert M; Van Roost D; Fimmers R; Bode U; Klockgether T
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):118-22. PubMed ID: 11413277
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
Chamberlain MC; Kormanik PA
Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
[TBL] [Abstract][Full Text] [Related]
12. Combined-modality treatment of leptomeningeal gliomatosis.
Chamberlain MC
Neurosurgery; 2003 Feb; 52(2):324-29; discussion 330. PubMed ID: 12535360
[TBL] [Abstract][Full Text] [Related]
13. Lymphomatous meningitis in immunocompetent patients.
Chamberlain M; Kormanik P
Oncol Rep; 1997; 4(6):1311-8. PubMed ID: 21590244
[TBL] [Abstract][Full Text] [Related]
14. Pediatric leptomeningeal metastases: outcome following combined therapy.
Chamberlain MC
J Child Neurol; 1997 Jan; 12(1):53-9. PubMed ID: 9010796
[TBL] [Abstract][Full Text] [Related]
15. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis.
Glantz MJ; Van Horn A; Fisher R; Chamberlain MC
Cancer; 2010 Apr; 116(8):1947-52. PubMed ID: 20151421
[TBL] [Abstract][Full Text] [Related]
16. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
18. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
Chamberlain MC; Kormanik PR
J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
20. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]